MedTech News
![](https://startllc.com/wp-content/uploads/2024/05/Monteris-NB3-laser-probe-1-300x195-1.jpg)
Monteris launches smallest brain laser probe on the market
Monteris Medical today said its launch of the NeuroBlate NB3 FullFire makes it the smallest laser probe for brain procedures on the market.
![](https://startllc.com/wp-content/uploads/2024/05/cook-medical-ascend-300x195-1.png)
Cook Medical launches Ascend single-use ureteroscope in U.S., Canada
Cook Medical this week launched its Ascend Single-Use Flexible Ureteroscope in the U.S. and Canada.
![](https://startllc.com/wp-content/uploads/2024/05/Toku-Eyes-300x191.jpg)
Toku Inc. Secures FDA Breakthrough Designation for Technology that Identifies Chronic Kidney Disease Risk Through the Eye
MyKidneyAI Becomes the Company’s Second Innovation to Recently Receive this FDA Distinction
![](https://startllc.com/wp-content/uploads/2024/05/Eversense-300x206.jpg)
Eversense® CGM System Receives iCGM Designation by the US FDA
The first fully implantable continuous glucose monitors can now be integrated with insulin pumps as part of an automated insulin delivery system
![](https://startllc.com/wp-content/uploads/2024/05/Route-92-Medical-FreeClimb-54-300x195-1.png)
FDA clears Route 92 Medical’s FreeClimb 54 reperfusion system
Route 92 Medical today announced it received FDA 510(k) clearance for its FreeClimb 54 reperfusion system.
![](https://startllc.com/wp-content/uploads/2024/05/Avive-300x146.jpg)
Axogen announces first surgical implant of Avive+ Soft Tissue Matrix
Axogen (Nasdaq:AXGN) this week announced the first surgical implantation of its Avive+ Soft Tissue Matrix.
![](https://startllc.com/wp-content/uploads/2024/05/Senseonics-Eversense-E3-Ascensia-Diabetes-Care-300x195-1.webp)
Senseonics wins integrated CGM designation from FDA, can work with insulin pumps
The FDA granted integrated CGM (iCGM) designation to the Eversense continuous glucose monitoring system from Senseonics (NYSE:SENS).
![](https://startllc.com/wp-content/uploads/2024/05/Abbott-Espirit-BTK-300x195-1.jpg)
Abbott wins FDA approval for dissolving drug-eluting scaffold
Abbott (NYSE: ABT)+
announced today that the FDA approved its Esprit everolimus-eluting resorbable scaffold system.